Frequent Large Germline HRPT2 Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism

被引:93
作者
Bricaire, Leopoldine [1 ,2 ]
Odou, Marie-Francoise [3 ]
Cardot-Bauters, Catherine [4 ,5 ]
Delemer, Brigitte [6 ]
North, Marie-Odile [7 ]
Salenave, Sylvie [11 ]
Vezzosi, Delphine [10 ]
Kuhn, Jean-Marc [12 ,13 ]
Murat, Arnaud [14 ]
Caron, Philippe [10 ]
Sadoul, Jean-Louis
Silve, Caroline [18 ,19 ,20 ]
Chanson, Philippe [11 ,15 ]
Barlier, Anne [16 ,17 ]
Clauser, Eric [7 ,23 ]
Porchet, Nicole [3 ,21 ,22 ]
Groussin, Lionel [8 ,9 ,23 ]
机构
[1] Univ Paris 06, Fac Med, F-75005 Paris, France
[2] Hop St Antoine, AP HP, Serv Endocrinol, F-75012 Paris, France
[3] Univ Lille 2, Fac Pharm, Dept Oncol & Genet Mol, F-59037 Lille, France
[4] Ctr Hosp Reg & Univ Lille, Clin Marc Linquette, Serv Biochim & Biol Mol HMNO Hormonol Metab Nutr, F-59037 Lille, France
[5] Ctr Hosp Reg & Univ Lille, Clin Marc Linquette, Serv Med Interne & Endocrinol, F-59037 Lille, France
[6] Ctr Hosp Univ Reims, Serv Endocrinol Diabet Nutr, F-51092 Reims, France
[7] Hop Cochin, AP HP, Oncogenet Lab, F-75014 Paris, France
[8] Hop Cochin, AP HP, Dept Endocrinol, F-75014 Paris, France
[9] CNRS, UMR 8104, Inst Cochin, INSERM,U1016,Dept Endocrinol Metab & Canc, F-75014 Paris, France
[10] Ctr Hosp Univ Rangueil Larrey, Dept Endocrinol & Metab Dis, F-31059 Toulouse, France
[11] Hop Bicetre, Hop Univ Paris Sud, AP HP, Serv Endocrinol & Malad Reprod, F-94275 Le Kremlin Bicetre, France
[12] Ctr Hosp Univ, Serv Endocrinol, F-76031 Rouen, France
[13] Ctr Hosp Univ, INSERM, CIC0204, F-76031 Rouen, France
[14] CHU Nantes, Hop Nord Laennec, Serv Endocrinol, F-44035 Nantes, France
[15] Univ Paris Sud, Fac Med Paris Sud, UMR S693, F-94276 Le Kremlin Bicetre, France
[16] Aix Marseille Univ, CNRS, UMR 7286, CRN2M, F-13344 Marseille, France
[17] Assistance Publ Hop Marseille, Mol Biol Lab, F-13385 Marseille, France
[18] Hop Bicetre, INSERM, U986, F-94275 Le Kremlin Bicetre, France
[19] Hop Bicetre, Ctr Reference Malad Rares Metab Phosphocalc, F-94275 Le Kremlin Bicetre, France
[20] Hop Bichat Claude Bernard, AP HP, Lab Biochim Hormonale & Genet, F-75018 Paris, France
[21] Ctr Rech JP Aubert, UMR, U837, Equipe 5, F-59045 Lille, France
[22] Univ Lille Nord France, F-59044 Lille, France
[23] Univ Paris 05, Fac Med, F-75006 Paris, France
关键词
JAW TUMOR SYNDROME; FAMILIAL ISOLATED HYPERPARATHYROIDISM; PARATHYROID CARCINOMA; HEREDITARY HYPERPARATHYROIDISM; ENCODING PARAFIBROMIN; HPT-JT; GENE; MUTATIONS; PROTEIN;
D O I
10.1210/jc.2012-2789
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant syndrome with incomplete penetrance that can associate in a single patient parathyroid adenoma or carcinoma, fibro-osseous jaw tumor, cystic kidney lesion, and uterine tumor. Germline mutations of the HRPT2 gene (CDC73) coding for parafibromin are identified in approximately 50%-75% of HPT-JT cases and in approximately 14% of familial isolated hyperparathyroidism. A whole deletion of this gene has recently been reported in 1 sporadic case and in a family presenting with HPT-JT. Objective: The objective of the study was to report molecular abnormalities of the HRPT2 gene in patients with primary hyperparathyroidism in a French National cohort from the Groupe d'Etude des Tumeurs Endocrines. Methods: Patients' genomic DNA was screened by PCR-based sequencing for point mutations affecting HRPT2 and real-time quantitative PCR analysis for gross deletions. Results: We report 20 index patients with a germinal HRPT2 abnormality. Median age at diagnosis of primary hyperparathyroidism was 23 years (range 14-65 years). Median serum total calcium level at diagnosis was 3.19 mmol/L (range 2.8-4.3 mmol/L). Thirteen different mutations were identified by routine sequencing, including 7 mutations never reported. Seven patients (35%) carried a gross deletion of this gene (3 complete and 4 partial deletions). No genotype-phenotype correlation could be identified. Agross deletion of the HRPT2 gene was identified in 7% of patients for whom a routine screening by direct sequencing came up as negative. Conclusion: Gross deletion analysis of the HRPT2 gene is indicated for all patients negative for mutation, presenting with HPT-JT or familial isolated hyperparathyroidism, parathyroid carcinoma, or in patients with apparently sporadic parathyroid adenoma diagnosed at a young age, having a severe hypercalcemia. (J Clin Endocrinol Metab 98: E403-E408, 2013)
引用
收藏
页码:E403 / E408
页数:6
相关论文
共 27 条
  • [1] Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism
    Bradley, KJ
    Cavaco, BM
    Bowl, MR
    Harding, B
    Young, A
    Thakker, RV
    [J]. JOURNAL OF MEDICAL GENETICS, 2005, 42 (08) : e51
  • [2] Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome
    Bradley, KJ
    Hobbs, MR
    Buley, ID
    Carpten, JD
    Cavaco, BM
    Fares, JE
    Laidler, P
    Manek, S
    Robbins, CM
    Salti, IS
    Thompson, NW
    Jackson, CE
    Thakker, RV
    [J]. JOURNAL OF INTERNAL MEDICINE, 2005, 257 (01) : 18 - 26
  • [3] Carlson D, 2010, ARCH PATHOL LAB MED, V134, P1639, DOI 10.1043/2009-0578-CCR.1
  • [4] Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation
    Caron, Philippe
    Simonds, William F.
    Maiza, Jean-Christophe
    Rubin, Mishaela
    Cantor, Tom
    Rousseau, Louise
    Bilezikian, John P.
    Souberbielle, Jean-Claude
    D'Amour, Pierre
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 74 (06) : 694 - 698
  • [5] High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism
    Caron, Philippe
    Maiza, Jean Christophe
    Renaud, Claire
    Cormier, Catherine
    Barres, Beatrice Herbault
    Souberbielle, Jean Claude
    [J]. CLINICAL ENDOCRINOLOGY, 2009, 70 (04) : 533 - 538
  • [6] HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
    Carpten, JD
    Robbins, CM
    Villablanca, A
    Forsberg, L
    Presciuttini, S
    Bailey-Wilson, J
    Simonds, WF
    Gillanders, EM
    Kennedy, AM
    Chen, JD
    Agarwal, SK
    Sood, R
    Jones, MP
    Moses, TY
    Haven, C
    Petillo, D
    Leotlela, PD
    Harding, B
    Cameron, D
    Pannett, AA
    Höög, A
    Heath, H
    James-Newton, LA
    Robinson, B
    Zarbo, RJ
    Cavaco, BM
    Wassif, W
    Perrier, ND
    Rosen, IB
    Kristoffersson, U
    Turnpenny, PD
    Farnebo, LO
    Besser, GM
    Jackson, CE
    Morreau, H
    Trent, JM
    Thakker, RV
    Marx, SJ
    Teh, BT
    Larsson, C
    Hobbs, MR
    [J]. NATURE GENETICS, 2002, 32 (04) : 676 - 680
  • [7] Detection of the First Gross CDC73 Germline Deletion in an HPT-JT Syndrome Family
    Cascon, Alberto
    Vazquez Huarte-Mendicoa, Carlos
    Javier Leandro-Garcia, L.
    Leton, Rocio
    Suela, Javier
    Santana, Alfredo
    Boronat Costa, Mauro
    Comino-Mendez, Inaki
    Landa, Inigo
    Sanchez, Lydia
    Rodriguez-Antona, Cristina
    Cigudosa, Juan C.
    Robledo, Mercedes
    [J]. GENES CHROMOSOMES & CANCER, 2011, 50 (11) : 922 - 929
  • [8] Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
    Cetani, Filomena
    Ambrogini, Elena
    Viacava, Paolo
    Pardi, Elena
    Fanelli, Giovanni
    Naccarato, Antonio Giuseppe
    Borsari, Simona
    Lemmi, Monica
    Berti, Piero
    Miccoli, Paolo
    Pinchera, Aldo
    Marcocci, Claudio
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (05) : 547 - 554
  • [9] Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism
    Domingues, Rita
    Tomaz, Rute Alexandra
    Martins, Carmo
    Nunes, Carla
    Bugalho, Maria Joao
    Cavaco, Branca Maria
    [J]. CLINICAL ENDOCRINOLOGY, 2012, 76 (01) : 33 - 38
  • [10] CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum
    Frank-Raue, Karin
    Haag, Christine
    Schulze, Egbert
    Keuser, Roger
    Raue, Friedhelm
    Dralle, Henning
    Lorenz, Kerstin
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (03) : 477 - 483